The failures of socialized medicine stem not from malice, but from inherent incentives: monopolistic structures, political allocation of resources, and suppressed innovation.
I am regularly astonished at how many people — often younger folks — praise the supposed benefits of socialism and single‑payer health care. Despite extensive evidence to the contrary, and despite daily tragedies in systems that have adopted these models, the calls for more government intervention never seem to stop.
Socialized medicine, exemplified by Britain’s National Health Service (NHS), was founded on noble ideals: universal access to care “free at the point of use,” funded collectively as a national treasure. Yet the system now struggles with chronic shortages, soaring wait times, and structural failures that disproportionately harm the elderly and the disabled. Similar patterns are emerging in Canada with Medical Assistance in Dying (MAiD). These systems illustrate how government monopolies — despite high spending — often produce rationing, inefficiency, and desperation rather than dependable care.
Millions of people in England sit on waiting lists, including “unseen patients” referred by general practitioners (GPs) but never contacted for treatment. This is not a temporary post‑COVID anomaly; it is a systemic breakdown. Thousands wait more than 12 hours for emergency admission, and ambulance response times for strokes and heart attacks routinely exceed targets, contributing to rising excess deaths.
Elderly Britons are especially affected. Reports describe seniors feeling “fobbed off,” struggling to access GPs, facing canceled operations, and falling through gaps in social care. Surveys show that two‑thirds of people over 50 doubt the NHS can cope, and many express despair. Patients battle phone queues and online portals, often without ever seeing a doctor.
Backlogs also endanger older patients with sight‑threatening conditions such as macular degeneration or glaucoma. Many must wait months — or pay privately — to avoid permanent vision loss. Clinics reportedly prioritize simpler, better‑reimbursed cataract procedures, leaving complex cases to languish. One patient described waiting 16 weeks instead of the usual eight for essential injections.
The first objection from defenders of the NHS is almost always funding. Yet spending has risen dramatically for decades, now consuming roughly 43.1% of government expenditures on goods and services and growing faster than the economy on a per‑capita basis. Despite this, productivity lags, bed availability has fallen, and fewer patients are treated — largely due to bureaucracy and poor coordination with social care. One source states that, “If the NHS itself were a military, it would have the third-highest budget in the world, surpassed only by the U.S. and China.”
Social‑care bottlenecks worsen the crisis. Elderly patients who are medically ready for discharge often remain hospitalized for weeks because home‑care support is unavailable. This blocks beds, inflates costs, and strains staff. Care‑work wages are so low that retail jobs often pay more, leaving chronic vacancies in a rapidly aging society.
Canada’s experience with MAiD reveals different but related risks. Disability‑rights groups report disproportionate impacts: 42% of MAiD deaths from 2019–2023 involved people needing disability supports, and more than 1,000 never received those supports at all. In Ontario, disabled individuals were the most likely to die via MAiD, with nearly half citing loneliness or feeling like a burden. In another case, Canadian military veteran Christine Gauthier applied for a home chair lift from Veterans Affairs Canada (VAC). She claims they offered her MAiD instead.
In the United States, some Democrat‑led states required nursing homes to accept COVID‑positive patients, resulting in thousands of elderly deaths. While not an example of fully socialized medicine, these policies reflect centralized decision‑making that can prioritize political goals over vulnerable lives.
Ultimately, there are only two ways to allocate scarce resources: by time (rationing) or by price. In systems without profit motives or competition, incentives favor high‑volume, simple cases over complex elderly care. Aging populations increase demand for chronic and end‑of‑life services, but fixed budgets and political priorities lead to underinvestment in diagnostic equipment, beds, and staff. Public satisfaction with the NHS has fallen to historic lows — around 21% in some surveys — and the system underperforms peer nations in avoidable mortality and cancer survival.
Elderly patients, who have the least time to wait, bear the heaviest burden. They face worsening frailty, preventable blindness, untreated pain, and loss of dignity. Systems that promise “everything for free” often deliver long lines, denial of care, or — in extreme cases — pressure toward death. By contrast, countries that incorporate market‑oriented elements tend to show better responsiveness, more choice, and superior outcomes at similar spending levels.
The failures of socialized medicine stem not from malice, but from inherent incentives: monopolistic structures, political allocation of resources, and suppressed innovation. The elderly — who built these societies and rely on them most — pay the price in suffering, lost independence, and shortened lives.
Reform toward competition, patient empowerment, and realistic funding is essential if we hope to restore care worthy of the name.
American Thinker
THE ARTFUL DILETTANTE 